You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA

 

Online download statistics by month:

Online download statistics by month: November 2020 to February 2026

AbstractFullPdf
Nov 2020308310249
Dec 202022822894
Jan 202111411446
Feb 2021656557
Mar 202110510556
Apr 2021787842
May 2021626230
Jun 2021797941
Jul 2021777765
Aug 2021848666
Sep 2021818159
Oct 2021858771
Nov 2021969682
Dec 2021595939
Jan 2022717341
Feb 2022404037
Mar 2022124124103
Apr 2022858663
May 2022919259
Jun 2022778442
Jul 2022768253
Aug 202211711933
Sep 2022828257
Oct 2022636659
Nov 2022626338
Dec 2022596027
Jan 2023373735
Feb 202310010045
Mar 2023444539
Apr 2023394031
May 2023393923
Jun 2023353525
Jul 2023393926
Aug 2023444517
Sep 2023494926
Oct 2023535323
Nov 2023535329
Dec 2023707027
Jan 2024596032
Feb 2024848654
Mar 202419319672
Apr 2024454627
May 2024616125
Jun 2024585934
Jul 2024627536
Aug 2024374128
Sep 2024454527
Oct 2024535931
Nov 2024535729
Dec 2024686945
Jan 2025808145
Feb 2025474725
Mar 2025606137
Apr 2025798038
May 2025303033
Jun 2025323216
Jul 2025110
Feb 2026111
Total421842902590